Literature DB >> 10934202

A cellular protein, hnRNP H, binds to the negative regulator of splicing element from Rous sarcoma virus.

B L Fogel1, M T McNally.   

Abstract

Incomplete RNA splicing is a key feature of the retroviral life cycle. This is in contrast to the processing of most cellular pre-mRNAs, which are usually spliced to completion. In Rous sarcoma virus, splicing control is achieved in part through a cis-acting RNA element termed the negative regulator of splicing (NRS). The NRS is functionally divided into two parts termed NRS5' and NRS3', which bind a number of splicing factors. The U1 and U11 small nuclear ribonucleoproteins interact with sequences in NRS3', whereas NRS5' binds several proteins including members of the SR [corrected] family of proteins. Among the proteins that specifically bind NRS5' is a previously unidentified 55-kDa protein (p55). In this report we describe the isolation and identification of p55. The p55 binding site was localized by UV cross-linking to a 31-nucleotide segment, and a protein that binds specifically to it was isolated by RNA affinity selection and identified by mass spectrometry as hnRNP H. Antibodies against hnRNP H immunoprecipitated cross-linked p55 and induced a supershift of a p55-containing complex formed in HeLa nuclear extract. Furthermore, UV cross-linking and electrophoretic mobility shift assays indicated that recombinant hnRNP H specifically interacts with the p55 binding site, confirming that hnRNP H is p55. The possible roles of hnRNP H in NRS function are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934202     DOI: 10.1074/jbc.M005000200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor.

Authors:  Javier Cabello-Villegas; Keith E Giles; Ana Maria Soto; Ping Yu; Annie Mougin; Karen L Beemon; Yun-Xing Wang
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

2.  Retroviral splicing suppressor sequesters a 3' splice site in a 50S aberrant splicing complex.

Authors:  Keith E Giles; Karen L Beemon
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

3.  The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation.

Authors:  Jeremy E Wilusz; Karen L Beemon
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.

Authors:  Nicole L Maciolek; Mark T McNally
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

5.  A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F.

Authors:  Joel L Coles; Martina Hallegger; Christopher W J Smith
Journal:  RNA       Date:  2008-11-26       Impact factor: 4.942

6.  Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity.

Authors:  Joseph A Jablonski; Massimo Caputi
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

7.  Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element.

Authors:  Brent L Fogel; Lisa M McNally; Mark T McNally
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

8.  The secondary structure of the human immunodeficiency virus type 1 transcript modulates viral splicing and infectivity.

Authors:  Joseph A Jablonski; Emanuele Buratti; Cristiana Stuani; Massimo Caputi
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

9.  In vivo detection of RNA-binding protein interactions with cognate RNA sequences by fluorescence resonance energy transfer.

Authors:  Martina Huranová; Joseph A Jablonski; Ales Benda; Martin Hof; David Stanek; Massimo Caputi
Journal:  RNA       Date:  2009-09-18       Impact factor: 4.942

10.  Splice site strength-dependent activity and genetic buffering by poly-G runs.

Authors:  Xinshu Xiao; Zefeng Wang; Minyoung Jang; Razvan Nutiu; Eric T Wang; Christopher B Burge
Journal:  Nat Struct Mol Biol       Date:  2009-09-13       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.